Ocular Manifestations in Cutaneous Autoimmune Connective Tissue Diseases

Purpose: To study the prevalence of ophthalmic manifestations in cutaneous autoimmune connective tissue diseases, to monitor the progression of ocular manifestations. Methods: Retrospective, non-comparative, observational cohort study in tertiary care hospital, from July 2022 to December 2022, in 40 adult patients, with cutaneous autoimmune connective tissue disease. The demographic data, history, ophthalmic examination including visual acuity, slit lamp examination, dry eye tests, and fundus examination visual field test were recorded. Results: Majority of patients were in the age group 31-40 years (55%). The prevalence of ocular manifestations in cutaneous autoimmune connective tissue diseases was 72.5%. Wherein 79.3 % patients had anterior segment involvement and 20.7% patients had posterior segment involvement. Rheumatoid arthritis being the most common disease with ocular manifestations 57.5%. Conclusions: In cutaneous autoimmune connective tissue diseases, prevalence of ocular manifestations in our study was 72.5%. Females were more commonly and aggressively affected. It is essential to screen patients for ocular manifestations.